Home > Qtrly Results > INDOCO REMEDIES

INDOCO REMEDIES
Quarterly Results Analysis [Dec2023]

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
Audited
Mar2022
Audited
Revenues ₹459 Cr ₹482 Cr ₹427 Cr ₹428 Cr ₹399 Cr ₹433 Cr ₹408 Cr ₹409 Cr
Expenses ₹397 Cr ₹410 Cr ₹365 Cr ₹363 Cr ₹337 Cr ₹345 Cr ₹337 Cr ₹329 Cr
Operating Income ₹63 Cr ₹71 Cr ₹61 Cr ₹65 Cr ₹62 Cr ₹88 Cr ₹71 Cr ₹81 Cr
Other Income ₹2 Cr ₹4 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr
Interest ₹10 Cr ₹8 Cr ₹8 Cr ₹9 Cr ₹7 Cr ₹5 Cr ₹4 Cr ₹3 Cr
Depreciation ₹24 Cr ₹21 Cr ₹20 Cr ₹18 Cr ₹17 Cr ₹16 Cr ₹20 Cr ₹18 Cr
Profit Before Tax ₹23 Cr ₹46 Cr ₹34 Cr ₹39 Cr ₹38 Cr ₹67 Cr ₹48 Cr ₹60 Cr
Profit After Tax ₹16 Cr ₹35 Cr ₹24 Cr ₹26 Cr ₹28 Cr ₹50 Cr ₹39 Cr ₹40 Cr
EPS ₹1.77 ₹3.81 ₹2.65 ₹2.80 ₹3.05 ₹5.40 ₹4.19 ₹4.39
Industry Peers & Returns1W1M1Y
INDOCO REMEDIES -0.1% -11.7% 1.9%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

INDOCO REMEDIES Quarterly Revenues

Revenues
Q-o-Q

-4.63 %

Y-o-Y

15.09 %

Quarters Revenues % Change
Dec2023 ₹459 Cr
-4.63
Sep2023 ₹482 Cr
12.95
Jun2023 ₹427 Cr
-0.39
Mar2023 ₹428 Cr
7.25
Dec2022 ₹399 Cr
-7.81
Sep2022 ₹433 Cr
6.08
Jun2022 ₹408 Cr
-0.22
Mar2022 ₹409 Cr -

INDOCO REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-11.87 %

Y-o-Y

1.39 %

Quarters Operating Profit % Change
Dec2023 ₹63 Cr
-11.87
Sep2023 ₹71 Cr
16.67
Jun2023 ₹61 Cr
-5.54
Mar2023 ₹65 Cr
4.38
Dec2022 ₹62 Cr
-29.38
Sep2022 ₹88 Cr
22.95
Jun2022 ₹71 Cr
-11.29
Mar2022 ₹81 Cr -
Operating Margins
Q-o-Q

-7.62 %

Y-o-Y

-11.90 %

Quarters Operating Margin% % Change
Dec2023 13.69%
-7.62
Sep2023 14.82%
3.35
Jun2023 14.34%
-5.22
Mar2023 15.13%
-2.64
Dec2022 15.54%
-23.41
Sep2022 20.29%
15.94
Jun2022 17.5%
-11.12
Mar2022 19.69% -

INDOCO REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-55.85 %

Y-o-Y

-44.72 %

Quarters Profit After Tax % Change
Dec2023 ₹16 Cr
-55.85
Sep2023 ₹35 Cr
45.74
Jun2023 ₹24 Cr
-6.32
Mar2023 ₹26 Cr
-8.31
Dec2022 ₹28 Cr
-43.39
Sep2022 ₹50 Cr
28.93
Jun2022 ₹39 Cr
-4.65
Mar2022 ₹40 Cr -
PAT Margins
Q-o-Q

-53.69 %

Y-o-Y

-51.91 %

Quarters PAT Margin(%) % Change
Dec2023 3.39 %
-53.69
Sep2023 7.32 %
29.10
Jun2023 5.67 %
-5.97
Mar2023 6.03 %
-14.47
Dec2022 7.05 %
-38.59
Sep2022 11.48 %
21.48
Jun2022 9.45 %
-4.45
Mar2022 9.89 % -

INDOCO REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-53.54 %

Y-o-Y

-41.97 %

Quarters EPS % Change
Dec2023 ₹1.77
-53.54
Sep2023 ₹3.81
43.77
Jun2023 ₹2.65
-5.36
Mar2023 ₹2.8
-8.20
Dec2022 ₹3.05
-43.52
Sep2022 ₹5.4
28.88
Jun2022 ₹4.19
-4.56
Mar2022 ₹4.39 -

You may also like the below Video Courses